Teacher Retirement System of Texas increased its position in Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) by 126.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,194 shares of the company's stock after buying an additional 13,487 shares during the period. Teacher Retirement System of Texas' holdings in Privia Health Group were worth $824,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the company. Barclays PLC lifted its position in shares of Privia Health Group by 213.7% in the third quarter. Barclays PLC now owns 30,777 shares of the company's stock worth $1,048,000 after buying an additional 20,967 shares in the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in shares of Privia Health Group in the third quarter worth about $656,000. Victory Capital Management Inc. lifted its position in shares of Privia Health Group by 3,134.9% in the third quarter. Victory Capital Management Inc. now owns 241,908 shares of the company's stock worth $8,239,000 after buying an additional 234,430 shares in the last quarter. Lisanti Capital Growth LLC bought a new stake in Privia Health Group during the third quarter worth approximately $4,688,000. Finally, Assetmark Inc. increased its stake in Privia Health Group by 35.2% during the third quarter. Assetmark Inc. now owns 1,207 shares of the company's stock worth $41,000 after acquiring an additional 314 shares during the last quarter. 66.83% of the stock is currently owned by hedge funds and other institutional investors.
Get
Privia Health Group alerts:
Privia Health Group Stock Down 6.3 %
Shares of NASDAQ:PRVA opened at $25.96 on Friday. Privia Health Group, Inc. has a 52-week low of $17.99 and a 52-week high of $44.64. The stock has a market cap of $2.97 billion, a P/E ratio of -72.11 and a beta of 0.81. The business's 50 day moving average is $24.15 and its 200 day moving average is $31.01.
Privia Health Group (NASDAQ:PRVA – Get Rating) last announced its quarterly earnings data on Thursday, November 10th. The company reported $0.01 earnings per share (EPS) for the quarter. Privia Health Group had a negative return on equity of 6.82% and a negative net
margin of 3.02%. The company had revenue of $342.90 million for the quarter, compared to analysts' expectations of $323.66 million. On average, sell-side analysts anticipate that Privia Health Group, Inc. will post -0.26 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the company. The Goldman Sachs Group assumed coverage on Privia Health Group in a research note on Friday. They set a "buy" rating and a $32.00 price objective on the stock. Canaccord Genuity Group reduced their price objective on Privia Health Group from $50.00 to $43.00 and set a "buy" rating on the stock in a research note on Friday, November 11th. Stifel Nicolaus assumed coverage on Privia Health Group in a research note on Thursday, December 8th. They set a "buy" rating and a $28.00 price objective on the stock. SVB Leerink reduced their price objective on Privia Health Group from $46.00 to $39.00 and set an "outperform" rating on the stock in a research note on Friday, November 11th. Finally, BTIG Research reduced their price objective on Privia Health Group from $45.00 to $40.00 in a research note on Monday, January 9th. Thirteen analysts have rated the stock with a buy rating, According to MarketBeat.com, Privia Health Group has an average rating of "Buy" and an average target price of $38.93.
Insider Buying and Selling
In related news, Director William M. Sullivan sold 18,153 shares of the stock in a transaction that occurred on Friday, November 11th. The stock was sold at an average price of $27.56, for a total value of $500,296.68. Following the transaction, the director now owns 6,172,493 shares of the company's stock, valued at $170,113,907.08. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Privia Health Group news, Director William M. Sullivan sold 285,027 shares of the company's stock in a transaction on Monday, November 21st. The stock was sold at an average price of $22.56, for a total transaction of $6,430,209.12. Following the completion of the sale, the director now owns 5,887,466 shares in the company, valued at $132,821,232.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director William M. Sullivan sold 18,153 shares of the company's stock in a transaction on Friday, November 11th. The stock was sold at an average price of $27.56, for a total value of $500,296.68. Following the sale, the director now owns 6,172,493 shares of the company's stock, valued at approximately $170,113,907.08. The disclosure for this sale can be found here. Insiders have sold a total of 3,583,757 shares of company stock valued at $81,067,912 over the last quarter. 57.60% of the stock is owned by corporate insiders.
Privia Health Group Company Profile
(Get Rating)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Recommended Stories
- Get a free copy of the StockNews.com research report on Privia Health Group (PRVA)
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- Insiders And Institutions Buy Wolverine Worldwide
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
